To the Editor: Mucormycosis and aspergillosis are opportunistic fungal infections that can lead to lifethreatening complications. [1, 2] Pulmonary actinomycosis is a rare infection which is commonly confused with other lung diseases. [3] Co-infection with these three pathogens in the same host is rare. Here, we report a unique case of a cavitary lesion with aspergillosis, mucormycosis, and actinomycosis co-infection.
A 52-year-old male patient with type 2 diabetes presented at Fujian Medical University Union Hospital with a 2-month history of fever, cough, expectoration, and muscle soreness. Chest computed tomography (CT) scans revealed a large irregular cavitary lesion in his right upper lobe (RUL) [ Figure 1A ]. Following antibacterial therapy, CT showed that his lobar pneumonia had partially disappeared but lung abscesses had formed [ Figure 1B ]. The sound from his right lung was slightly quieter than from the left lung; moist rales were heard from both sides.
Investigations showed elevated leukocytes (15.31 Â 10 9 /L) and serum creatinine (178 mmol/L), plus hypoxemia (arterial partial pressure of oxygen [PaO 2 ] 66.6 mmHg). He had poor blood-glucose control (glycosylated hemoglobin 8.3%). Serum procalcitonin, fungal glucan, and Cryptococcus capsule antigen tests were negative. A serum galactomannan test (GM test) was positive (0.56). No pathogens were detected in sputum sample cultures, although Candida albicans was cultured (100 cfu/mL). Sputum smears for acid-fast bacilli and cancer cells were negative. Bronchoscopy revealed purulent sputum blocking the RUL bronchus [ Figure 1E ]. A bronchoalveolar lavage fluid (BALF) GM test was positive (4.51). Microbiology/pathology results confirmed aspergillosis infection.
The patient received meropenem and voriconazole for 2 weeks while aspergillosis was confirmed. CT revealed an irregular thick-walled cavity in the RUL [ Figure 1C ]. Oral voriconazole was continued. One month later, another bronchoscopy showed the RUL bronchus was completely obstructed by a granulomatous neoplasm [ Figure 1F ]; BALF GM test was positive (1.78). Pathologic results were different, with fungal mycelia observed, including Mucor [ Figure 1H ] and Aspergillus [ Figure 1I ]. Mucormycosis was confirmed; therefore, we recommended amphotericin B or posaconazole; the patient refused because he had renal dysfunction.
His intermittent fever remained; coughing, shortness of breath, and pneumonia worsened [ Figure 1D ]; blood creatinine increased to 260 mmol/L. Meropenem and posaconazole were given. Bronchoscopy showed the RUL bronchus completely obstructed by a yellowish granulomatous neoplasm which moved up and down as he respired [ Figure 1G ]. A further BALF GM test was positive (5.09). Pathology showed that fungal mycelia of Aspergillus were observed in the background of Actinomycetes [ Figure 1J ]. The patient refused amphotericin B again; piperacillin-tazobactam was substituted for meropenem and oral posaconazole was continued.
After 6 months, no improvement was seen, so pulmonary lobectomy was performed. Post-operative pathology showed a mycotic mass of Aspergillus. The patient went into remission.
Mucormycosis and aspergillosis are opportunistic, potentially fatal invasive fungal infections; co-infection usually occurs in the orofacial area or sinuses. [1, 2] Pulmonary actinomycosis is rare and frequently confused with other pulmonary diseases; therefore, correct diagnosis is challenging, often leading to delayed or misdiagnosis. [3] Treatment of such co-infections requires prompt diagnosis, appropriate treatment, and, if necessary, surgical resection.
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